Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17–24 years old
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17–24 years old ; volume:13 ; number:1 ; day:29 ; month:3 ; year:2023 ; pages:1-9 ; date:12.2023
Scientific reports ; 13, Heft 1 (29.3.2023), 1-9, 12.2023
- Creator
-
John, Steven A.
Zapata, Juan P.
Dang, Madeline
Pleuhs, Benedikt
O’Neil, Andrew
Hirshfield, Sabina
Walsh, Jennifer L.
Petroll, Andrew E.
Quinn, Katherine G.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-32014-8
- URN
-
urn:nbn:de:101:1-2023081421161786901866
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- John, Steven A.
- Zapata, Juan P.
- Dang, Madeline
- Pleuhs, Benedikt
- O’Neil, Andrew
- Hirshfield, Sabina
- Walsh, Jennifer L.
- Petroll, Andrew E.
- Quinn, Katherine G.
- SpringerLink (Online service)
Other Objects (12)
Pre-Exposure Prophylaxis (PrEP)
Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university
Optimizing Uptake of Long-Acting Injectable Pre-exposure Prophylaxis for HIV Prevention for Men Who Have Sex with Men
Attitude towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among HIV specialists
Ambivalence and the biopolitics of HIV pre-exposure prophylaxis (PrEP) implementation
Expanding Knowledge About Implementation of Pre-exposure Prophylaxis (PrEP): A Methodological Review
Antiretroviral Drug Treatment of Individuals that Used Preexposure Prophylaxis (PrEP) Before Diagnosis
Enhanced Oral Pre-exposure Prophylaxis (PrEP) Implementation for Ugandan Fisherfolk: Pilot Intervention Outcomes
Zero knowledge and high interest in the use of long-acting injectable pre-exposure prophylaxis (PrEP) among adolescent men who have sex with men and transgender women in two capital cities in Brazil
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States
Pre-Exposure Prophylaxis (PrEP)
Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university
Optimizing Uptake of Long-Acting Injectable Pre-exposure Prophylaxis for HIV Prevention for Men Who Have Sex with Men
Attitude towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among HIV specialists
Ambivalence and the biopolitics of HIV pre-exposure prophylaxis (PrEP) implementation
Expanding Knowledge About Implementation of Pre-exposure Prophylaxis (PrEP): A Methodological Review
Antiretroviral Drug Treatment of Individuals that Used Preexposure Prophylaxis (PrEP) Before Diagnosis
Enhanced Oral Pre-exposure Prophylaxis (PrEP) Implementation for Ugandan Fisherfolk: Pilot Intervention Outcomes
Zero knowledge and high interest in the use of long-acting injectable pre-exposure prophylaxis (PrEP) among adolescent men who have sex with men and transgender women in two capital cities in Brazil
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States
Pre-Exposure Prophylaxis (PrEP)
Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university
Optimizing Uptake of Long-Acting Injectable Pre-exposure Prophylaxis for HIV Prevention for Men Who Have Sex with Men
Attitude towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among HIV specialists
Ambivalence and the biopolitics of HIV pre-exposure prophylaxis (PrEP) implementation
Expanding Knowledge About Implementation of Pre-exposure Prophylaxis (PrEP): A Methodological Review
Antiretroviral Drug Treatment of Individuals that Used Preexposure Prophylaxis (PrEP) Before Diagnosis
Enhanced Oral Pre-exposure Prophylaxis (PrEP) Implementation for Ugandan Fisherfolk: Pilot Intervention Outcomes
Zero knowledge and high interest in the use of long-acting injectable pre-exposure prophylaxis (PrEP) among adolescent men who have sex with men and transgender women in two capital cities in Brazil